Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
814.00    -22.00 (-2.63%)
Bid:
814.00
Ask:
816.00
Spread: 2.00 (0.246%)
Market Cap: £767.56m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AUM Update

11 Jan 2018 07:00

RNS Number : 5307B
Polar Capital Holdings PLC
11 January 2018
 

11 January 2018 Polar Capital Holdings plc

AUM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist asset management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM") and performance fees earned for the calendar year to 31 December 2017.

 

Group AUM (unaudited)

 

Polar Capital reports that as at 31 December 2017 its AUM were £11.7bn compared to £9.3bn at the end of March 2017. AUM increased by £1.1bn in the quarter of which £597m were net inflows and £507m related to market movement and performance.

 

AUM movement in nine months to 31 December 2017

Long only

funds

Alternative funds

Total

AUM at

31 March 2017

£8,447m

£826m

£9,273m

Net subscriptions

£1,145m

£272m

£1,417m

Market movement

and performance

£952m

£65m

£1,017m

Total AUM at

31 December 2017

£10,544m

£1,163m

£11,707m

 

Comment

 

The Group has had a satisfactory quarter with pleasing net inflows despite the termination of four underperforming funds during the quarter.

 

This update confirms that the momentum of net inflows over the past quarters has continued and the final performance fee profits for the year that crystallised at the end of December are a significant improvement on last year's figure.

 

It is encouraging to report that the Group's investment teams are well placed in terms of performance and fund flows to continue their growth into 2018. The Group has a firm footing from which to implement its strategy of diversifying investment strategies, client domicile and client segments.

 

Net performance fees (unaudited)

 

The table below sets out the position relating to net performance fee profits (after the deduction of staff interests) earned in the first nine months of the Group's financial year.

 

Performance fee profit

net of staff allocations

Nine months to

31 Dec 16

Year to

31 Mar 17

(year-end)

Nine months to

31 Dec 17*

Net performance fee profit

£1.2m

£1.2m

£15.0m*

 

\* The figures to December 2017 are enhanced by £2.4m due to the IFRS requirement for the cost of deferred staff allocations to be spread over the period of deferment. The amount of net deferral will be reflected in the Adjusted Earnings Per Share figure that will be reported at the financial year-end.

 

For further information please contact:

 

Polar Capital

Gavin Rochussen (Chief Executive)John Mansell (COO)

+44 (0)20 7227 2700

Canaccord Genuity - Nomad and Joint Broker

Simon Bridges (QE)

Andrew Buchanan

Margarita Mitropoulou

+44 (0)20 7523 8000

 

Peel Hunt - Joint Broker

Guy Wiehahn

+44 (0)20 7418 8893

Camarco

Ed Gascoigne-Pees

 

+44 (0)20 3757 4984

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKFEFDAPEFF
Date   Source Headline
9th Aug 20213:39 pmRNSForm 8.3 - Restore PLC
6th Aug 20214:38 pmRNSForm 8.3 - RESTORE PLC
2nd Aug 20217:00 amRNSBlock listing Interim Review
2nd Aug 20217:00 amRNSDirector/PDMR Shareholding
23rd Jul 20213:44 pmRNSForm 8.3 - RESTORE PLC
20th Jul 20214:15 pmRNSDirector/PDMR Shareholding
19th Jul 20219:54 amRNSDirector/PDMR Shareholding
13th Jul 20211:02 pmRNSDirector/PDMR Shareholding
12th Jul 202112:38 pmRNSDirector/PDMR Shareholding
8th Jul 20212:07 pmRNSAnnual Financial Report
8th Jul 20217:00 amRNSAuM Update
1st Jul 202111:07 amRNSDividend Declaration
1st Jul 202110:26 amRNSDirector Declaration
1st Jul 20217:00 amRNSGroup Audited Results for year ended 31 March 2021
29th Jun 20213:53 pmRNSForm 8.3 - Ultra Electronics Holdings PLC
7th Jun 20217:00 amRNSNotice of Results
1st Jun 20217:00 amRNSTotal Voting Rights
26th May 20215:35 pmRNSDirector/PDMR Shareholding
21st May 20212:21 pmRNSDirector/PDMR Shareholding
20th May 202111:36 amRNSIssue of Equity
20th May 202110:38 amRNSHolding(s) in Company
19th May 20217:00 amRNSForm 8.3 - Immunodiagnostic Systems Holdings PLC
17th May 202112:45 pmRNSDirector/PDMR Shareholding
17th May 20217:00 amRNSDirector/PDMR Shareholding
17th May 20217:00 amRNSIssue of Equity
16th Apr 20217:00 amRNSDirector/PDMR Shareholding
15th Apr 20217:00 amRNSAuM Update
13th Apr 20214:27 pmRNSHolding(s) in Company
1st Apr 202110:44 amRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSTotal Voting Rights
25th Mar 20215:45 pmRNSHolding(s) in Company
18th Mar 20214:08 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSCompletion of Dalton SP LLP Acquisition
26th Feb 20214:33 pmRNSDirector/PDMR Shareholding
26th Feb 20214:32 pmRNSTotal Voting Rights
23rd Feb 20217:00 amRNSIssue of Equity
1st Feb 20215:35 pmRNSIssue of Equity
1st Feb 20217:00 amRNSBlock listing Interim Review
1st Feb 20217:00 amRNSTotal Voting Rights
25th Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 20217:00 amRNSIssue of Equity
20th Jan 20215:25 pmRNSDirector/PDMR Shareholding
20th Jan 20215:22 pmRNSIssue of Equity
19th Jan 20219:39 amRNSIssue of Equity
18th Jan 20217:00 amRNSDirector/PDMR Shareholding
15th Jan 20217:00 amRNSIssue of Equity
14th Jan 20217:00 amRNSAuM Update
17th Dec 20207:00 amRNSAcquisition of Dalton Strategic Partnership LLP

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.